Hiroshi Maruyama Selected Research

Hiroshi Maruyama Research Topics

Disease

20	Neoplasms (Cancer) 09/2019 - 01/2002
8	Melanoma (Melanoma, Malignant) 05/2019 - 06/2016
7	Stomach Neoplasms (Stomach Cancer) 04/2022 - 02/2008
7	Neoplasm Metastasis (Metastasis) 05/2019 - 02/2008
7	Carcinoma (Carcinomatosis) 04/2012 - 05/2003
6	Squamous Cell Carcinoma (Epidermoid Carcinoma) 07/2017 - 09/2003
5	Esophageal Neoplasms (Esophageal Cancer) 04/2012 - 08/2002
4	Vasculitis (Vasculitides) 01/2020 - 04/2016
3	Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis 01/2020 - 10/2016
3	Fabry Disease (Fabry's Disease) 01/2020 - 01/2016
3	Microscopic Polyangiitis 01/2020 - 10/2016
3	Skin Neoplasms (Skin Cancer) 11/2015 - 11/2011
3	Pituitary Neoplasms (Pituitary Adenoma) 11/2013 - 07/2012
3	Lymphatic Metastasis 04/2012 - 09/2006
3	Adenocarcinoma 03/2009 - 10/2005
2	Body Weight (Weight, Body) 08/2022 - 07/2008
2	Osteoporosis 03/2021 - 01/2019
2	Postmenopausal Osteoporosis 03/2021 - 01/2019
2	Infections 02/2021 - 01/2013
2	Ascites 04/2019 - 07/2008
2	Glomerulonephritis 01/2017 - 01/2013
2	Hyperthyroidism 06/2016 - 01/2014
2	Fever (Fevers) 06/2016 - 01/2008
2	Pathologic Complete Response 03/2015 - 06/2008
2	Cysts 01/2015 - 01/2011
2	Proteinuria 01/2014 - 01/2013
2	Rupture 01/2013 - 10/2004
2	Mesothelioma 06/2012 - 04/2012
2	Malignant Mesothelioma 04/2012 - 01/2012
2	Anorexia 07/2008 - 09/2006
1	Albuminuria 08/2022
1	Congenital Abnormalities (Deformity) 07/2022
1	Drug Hypersensitivity (Drug Allergy) 04/2022
1	Head and Neck Neoplasms (Head and Neck Cancer) 10/2021
1	Hepatocellular Carcinoma (Hepatoma) 05/2021
1	Thrombosis (Thrombus) 05/2021
1	Urinary Tract Infections (Urinary Tract Infection) 02/2021
1	Pneumonia (Pneumonitis) 02/2021
1	Enteritis 02/2021
1	Arteriovenous Fistula 11/2020
1	Disease Progression 01/2020
1	Anemia 05/2019

Drug/Important Bio-Agent (IBA)

7	NivolumabIBA 01/2018 - 06/2016
7	Fluorouracil (Carac)FDA LinkGeneric 04/2012 - 05/2003
5	Docetaxel (Taxotere)FDA Link 04/2012 - 05/2009
5	nedaplatinIBA 03/2011 - 05/2003
3	GalactosidasesIBA 01/2020 - 01/2016
3	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 01/2020 - 10/2016
3	Monoclonal AntibodiesIBA 05/2019 - 06/2016
3	Immune Checkpoint InhibitorsIBA 11/2018 - 09/2016
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 04/2017 - 08/2011
2	Denosumab FDA Link 03/2021 - 01/2019
2	C-Reactive ProteinIBA 01/2020 - 10/2016
2	globotriaosylceramide (globotriosylceramide)IBA 01/2020 - 11/2017
2	AntibodiesIBA 05/2019 - 01/2013
2	IpilimumabIBA 01/2018 - 11/2017
2	SteroidsIBA 11/2017 - 09/2016
2	Immunoglobulin G (IgG)IBA 01/2017 - 01/2007
2	CreatinineIBA 10/2016 - 01/2013
2	Immunoglobulin A (IgA)IBA 04/2016 - 01/2007
2	Capsules (Microcapsules)IBA 01/2015 - 01/2013
2	Transcription Factors (Transcription Factor)IBA 11/2013 - 05/2013
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 04/2013 - 05/2003
2	AutoantibodiesIBA 01/2013 - 01/2007
2	ErbB Receptors (EGF Receptor)IBA 06/2012 - 04/2012
2	Insulin (Novolin)FDA Link 05/2012 - 05/2004
2	Cisplatin (Platino)FDA LinkGeneric 04/2012 - 05/2003
2	Irinotecan (Camptosar)FDA LinkGeneric 07/2008 - 09/2006
1	Hemoglobins (Hemoglobin)IBA 08/2022
1	Sodium-Glucose Transport ProteinsIBA 08/2022
1	6- ((4- ethylphenyl)methyl)- 3',4',5',6'- tetrahydro- 6'- (hydroxymethyl)spiro(isobenzofuran- 1(3H),2'- (2H)pyran)- 3',4',5'- triolIBA 08/2022
1	Sodium-Glucose Transporter 2 InhibitorsIBA 08/2022
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 04/2022
1	fibrin fragment D (D-dimer)IBA 05/2021
1	Anti-Bacterial Agents (Antibiotics)IBA 02/2021
1	GlycosphingolipidsIBA 01/2020
1	Proteasome Endopeptidase Complex (Proteasome)IBA 01/2020
1	Tumor Biomarkers (Tumor Markers)IBA 05/2019
1	Programmed Cell Death 1 ReceptorIBA 05/2019

Therapy/Procedure

11	Drug Therapy (Chemotherapy) 04/2022 - 05/2003
7	Lymph Node Excision (Lymph Node Dissection) 10/2017 - 09/2003
7	Chemoradiotherapy 11/2013 - 05/2003
5	Therapeutics 11/2020 - 09/2006
4	Radiotherapy 10/2021 - 05/2003
4	Esophagectomy 01/2016 - 09/2003
3	Hepatectomy 05/2021 - 01/2011
3	Nephrectomy 09/2019 - 02/2008
3	Neoadjuvant Therapy 03/2015 - 04/2012
3	Argon Plasma Coagulation 11/2010 - 08/2002
3	Gastrectomy 07/2008 - 02/2008
2	Pedicle Screws 07/2022 - 03/2021
2	Catheters 02/2021 - 01/2015
2	Cholecystectomy 09/2019 - 01/2011
2	Aftercare (After-Treatment) 04/2017 - 06/2008
2	Punctures 01/2011 - 05/2008
2	Combination Drug Therapy (Combination Chemotherapy) 07/2009 - 05/2009
1	Length of Stay 02/2021
1	Renal Dialysis (Hemodialysis) 11/2020
1	Enzyme Replacement Therapy 01/2020
1	Adrenalectomy 09/2019